Researcher Profile and Settings

Researcher

• Name

  Kurata Morito

Profile and Settings

• Name

  Kurata, Morito

Other names

• Institute of Science Tokyo

Alternate Names

• Morihito Kurata

Affiliation

• Gunma University, Graduate School of Medicine Diagnostic Pathology, Professor

Association Memberships

• 9999

Research Experience

• Jul. 2025, 9999, Gunma University, Graduate School of Medicine Diagnostic Pathology, professor, Prof lv
• Oct. 2024, Jun. 2025, Institute of Science Tokyo, Hospital Division of Integrated Facilities Pathology / Graduate School of Medical and Dental Sciences, Surgical Pathology, Associate professor, Associate prof lecturer lv
• Apr. 2024, Sep. 2024, Tokyo Medical and Dental University，Division of Integrated Facilities，, Hospital Division of Integrated Facilities Pathology / Graduate School of Medical and Dental Sciences, Surgical Pathology, Associate Professor
• Sep. 2016, Mar. 2024, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Comprehensive Pathology, Junior Associate Professor
• Oct. 2013, Sep. 2016, University of Minnesota, Masonic Cancer Center, Visiting Associate Professor / Research Scholar
• Apr. 2013, Sep. 2013, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences， Comprehensive Pathology，, Junior Associate Professor
• Apr. 2007, Mar. 2013, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Advanced Therapeutic Sciences, Assistant Professor

Research Activities

Research Areas

• Life sciences, Experimental pathology
• Life sciences, Pathobiochemistry
• Life sciences, Tumor biology

Research Interests

• Microenvironment of bone marrow
• Pathology of bone marrow
• Oncogene
• Drug resistance
• CRISPR screening

Published Papers

• Effects of venetoclax, a BCL2 inhibitor, in systemic chronic active Epstein-Barr virus disease., Ayaka Ohashi; Miwako Nishio; Mayumi Yoshimori; Kaoru Koike; Morito Kurata; Hayato Tamai; Ken-Ichi Imadome; Ayako Arai, 27 May 2025, Scientific reports, 15, 1, 18569, 18569, Scientific journal

  DOI
• Identification of Target Genes Using Innovative Screening Systems., Keisuke Sugita; Morito Kurata, 05 May 2025, Pathology international, Scientific journal

  DOI
• Cytoplasmic HuR Expression Enhances Chemoresistance in Pleural Mesothelioma Through Increased Expression of CALB2, Promotion of the E2F Pathway, and Suppression of the p53 Pathway, Susumu Kirimura; Morito Kurata; Hironori Ishibashi; Yusuke Taniguchi; Yuko Kinowaki; Keisuke Sugita; Kenichi Okubo, 09 Apr. 2025, Thoracic Cancer, 16, 7, Scientific journal

  DOI
• Modified screening of MYC promotor region elements using the CRISPR library in ovarian cancer, Akiko Yamamoto; Yosuke Tanaka; Sachiko Ishibashi; Masumi Ikeda; Keisuke Sugita; Masanori Ono; Hirotaka Nishi; Morito Kurata, 02 Apr. 2025, Journal of Ovarian Research, 18, 1, Scientific journal

  DOI
• GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies, Hirotomo TAKAHARA; Takumi Kanazawa; Haruna Oshita; Yoshinobu Tomita; Yuri Hananoi; Sachiko Ishibashi; Masumi Ikeda; Asuka Furukawa; Mayumi Kinoshita; Kurara Yamamoto; Yuki Kato; Hironori Ishibashi; Kenichi Okubo; Morito Kurata; Masanobu Kitagawa; Kenichi Ohashi; Kouhei Yamamoto, Nov. 2024, Cancers, Scientific journal

  DOI
• A new model of extramedullary hematopoiesis., Morito Kurata; Iichiroh Onishi, 29 Aug. 2024, Blood, 144, 9, 921, 922, Scientific journal

  DOI
• Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer., Kazuhiro Tamura; Yoshinobu Tomita; Takumi Kanazawa; Hajime Shinohara; Masayoshi Sakano; Sachiko Ishibashi; Masumi Ikeda; Mayumi Kinoshita; Junko Minami; Kurara Yamamoto; Yuki Kato; Asuka Furukawa; Shigeo Haruki; Masanori Tokunaga; Yusuke Kinugasa; Morito Kurata; Masanobu Kitagawa; Kenichi Ohashi; Kouhei Yamamoto, 24 Aug. 2024, International journal of molecular sciences, 25, 17, Scientific journal

  DOI
• The Comprehensive Characterization of B7-H3 Expression in the Tumor Microenvironment of Lung Squamous Cell Carcinoma: A Retrospective Study., Ayaka Asakawa; Ryoto Yoshimoto; Maki Kobayashi; Nanae Izumi; Takanori Maejima; Tsuneo Deguchi; Kazuishi Kubota; Hisashi Takahashi; Miyuki Yamada; Sachiko Ishibashi; Iichiroh Onishi; Yuko Kinowaki; Morito Kurata; Masashi Kobayashi; Hironori Ishibashi; Kenichi Okubo; Kenichi Ohashi; Masanobu Kitagawa; Kouhei Yamamoto, 04 Jun. 2024, Cancers, 16, 11, Scientific journal

  DOI
• Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell Lymphoma., Genji Kawade; Morito Kurata; Yuko Matsuki; Sho Fukuda; Iichiroh Onishi; Yuko Kinowaki; Shiori Watabe; Sachiko Ishibashi; Masumi Ikeda; Masahide Yamamoto; Kenichi Ohashi; Masanobu Kitagawa; Kouhei Yamamoto, Apr. 2024, Laboratory investigation; a journal of technical methods and pathology, 104, 4, 102027, 102027, Scientific journal

  DOI
• Single-Nucleus Analysis Reveals Tumor Heterogeneity of Aldosterone-Producing Adenoma., Masanori Murakami; Kazunari Hara; Kenji Ikeda; Masato Horino; Rei Okazaki; Yoshihiro Niitsu; Akira Takeuchi; Jun Aoki; Kumiko Shiba; Kazutaka Tsujimoto; Chikara Komiya; Yuki Nakamura; Morito Kurata; Takumi Akashi; Yasuhisa Fujii; Tetsuya Yamada, Feb. 2024, Hypertension (Dallas, Tex. : 1979), 81, 2, 361, 371, Scientific journal

  DOI
• Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma., Takahiro Tsujikawa; Kazuchika Ohno; Kei-Ichi Morita; Sumiyo Saburi; Junichi Mitsuda; Kanako Yoshimura; Alisa Kimura; Hiroki Morimoto; Hiroshi Ogi; Saya Shibata; Takumi Akashi; Morito Kurata; Issei Imoto; Yasushi Shimizu; Satoshi Kano; Akihito Watanabe; Tomoko Yamazaki; Yukinori Asada; Ryuichi Hayashi; Yuki Saito; Hiroyuki Ozawa; Kiyoaki Tsukahara; Nobuhiko Oridate; Daisuke Sano; Arata Horii; Yushi Ueki; Takashi Maruo; Nobuaki Mukoyama; Nobuhiro Hanai; Takahito Fukusumi; Hiroshi Iwai; Takuo Fujisawa; Takashi Fujii; Ken-Ichi Nibu; Shigemichi Iwae; Tsutomu Ueda; Nobuyuki Chikuie; Ryuji Yasumatsu; Mioko Matsuo; Hirohito Umeno; Takeharu Ono; Muneyuki Masuda; Satoshi Toh; Kyoko Itoh; Shigeru Hirano; Takahiro Asakage, 2024, Frontiers in immunology, 15, 1390873, 1390873, Scientific journal

  DOI
• Gene expression profiling of pancreatic neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm, Yuko Kinowaki; Yuki Fukumura; Genji Kawade; Keisuke Sugita; Keiichi Kinowaki; Keiichi Akahoshi; Masanori Kobayashi; Hiroaki Ono; Atsushi Kudo; Minoru Tanabe; Takumi Akashi; Kenichi Ohashi; Morito Kurata, Oct. 2023, Gene, 147916, 147916, Scientific journal

  DOI
• Regulation of 4-HNE via SMARCA4 Is Associated with Worse Clinical Outcomes in Hepatocellular Carcinoma, Shiori Watabe; Yukari Aruga; RYOKO KATO; Genji Kawade; Yuki Kubo; Anna Tatsuzawa; Iichiroh Onishi; Yuko Kinowaki; Sachiko Ishibashi; Masumi Ikeda; Yuki Fukawa; Keiichi Akahoshi; Minoru Tanabe; Morito Kurata; Kenichi Ohashi; Masanobu Kitagawa; Kouhei Yamamoto, Aug. 2023, Biomedicines, Scientific journal

  DOI
• Indirect CRISPR screening with photoconversion revealed key factors of drug resistance with cell–cell interactions, Keisuke Sugita; Iichiroh Onishi; Ran Nakayama; Sachiko Ishibashi; Masumi Ikeda; Miori Inoue; Rina Narita; Shiori Oshima; Kaho Shimizu; Shinichiro Saito; Shingo Sato; Branden S. Moriarity; Kouhei Yamamoto; David A. Largaespada; Masanobu Kitagawa; Morito Kurata, 01 Jun. 2023, Communications Biology, 6, 1, Scientific journal

  DOI
• A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinemia., Takuji Itakura; Hirokazu Sasaki; Tadashi Hosoya; Taiki Yamaguchi; Erika Mimori; Yukino Saimon; Hideyuki Iwai; Natsuka Umezawa; Daisuke Kawata; Naoki Kimura; Morito Kurata; Masaki Shimizu; Shinsuke Yasuda, 24 Apr. 2023, Rheumatology (Oxford, England), Scientific journal

  DOI
• Chromosomal analysis of clonally related B-cell lymphomas with discordant immunoglobulin light-chain restrictions at different anatomical sites., Keisuke Nonaka; Morito Kurata; Moriaki Tachibana; Akiko Komatsu; Yuuki Shichi; Fujiya Gomi; Toshiyuki Ishiwata; Kou Miyamoto; Tomio Arai, 12 Dec. 2022, Pathology international, Scientific journal

  DOI
• Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer., Hajime Shinohara; Maki Kobayashi; Kumiko Hayashi; Daichi Nogawa; Ayaka Asakawa; Yae Ohata; Kazuishi Kubota; Hisashi Takahashi; Miyuki Yamada; Masanori Tokunaga; Yusuke Kinugasa; Goshi Oda; Tsuyoshi Nakagawa; Iichiroh Onishi; Yuko Kinowaki; Morito Kurata; Kenichi Ohashi; Masanobu Kitagawa; Kouhei Yamamoto, 31 Oct. 2022, International journal of molecular sciences, 23, 21, Scientific journal

  DOI
• Identification of NRAS Downstream Genes with CRISPR Activation Screening, Akiya Tatsumi; Haruka Hirakochi; Satomi Inoue; Yosuke Tanaka; Hidehiro Furuno; Masumi Ikeda; Sachiko Ishibashi; Towako Taguchi; Kouhei Yamamoto; Iichiroh Onishi; Zohar Sachs; David Largaespada; Masanobu Kitagawa; Morito Kurata, 23 Oct. 2022, Biology, 11, 11, 1551, 1551, Scientific journal

  DOI
• Identification of the Factor That Leads Human Mesenchymal Stem Cell Lines into Decellularized Bone, Anri Koyanagi; Iichiroh Onishi; Karin Muraoka; Ikue Sato; Shingo Sato; Tsuyoshi Kimura; Akio Kishida; Kouhei Yamamoto; Masanobu Kitagawa; Morito Kurata, 21 Sep. 2022, Bioengineering, 9, 10, 490, 490, Scientific journal

  DOI
• Quantitative high-throughput analysis of tumor infiltrating lymphocytes in breast cancer, Kumiko Hayashi; Daichi Nogawa; Maki Kobayashi; Ayaka Asakawa; Yae Ohata; Shota Kitagawa; Kazuishi Kubota; Hisashi Takahashi; Miyuki Yamada; Goshi Oda; Tsuyoshi Nakagawa; Hiroyuki Uetake; Iichiroh Onishi; Yuko Kinowaki; Morito Kurata; Masanobu Kitagawa; Kouhei Yamamoto, 05 Sep. 2022, Frontiers in Oncology, 12, Scientific journal

  DOI
• Proliferation and Self-Renewal Are Differentially Sensitive to NRASG12V Oncogene Levels in an Acute Myeloid Leukemia Cell Line, Morito Kurata; Marie Lue Antony; Klara E. Noble-Orcutt; Susan K. Rathe; Yoonkyu Lee; Hidehiro Furuno; Sachiko Ishibashi; Masumi Ikeda; Kouhei Yamamoto; Masanobu Kitagawa; David A. Largaespada; Zohar Sachs, 16 Aug. 2022, Molecular Cancer Research, 20, 11, OF1, OF13, Scientific journal

  DOI
• Endovascular Treatment for Acute Ischemic Stroke After Video-Assisted Thoracoscopic Pulmonary Lobectomy in Patients With Lung Cancer: A Report of Four Cases and Literature Review., Hiroshi Ueno; Hiroto Yamaoka; Sakyo Hirai; Kyohei Fujita; Mariko Ishikawa; Shoko Fujii; Yuki Aizawa; Yosuke Ishii; Masataka Yoshimura; Kenji Yamada; Yoshikazu Yoshino; Morito Kurata; Katsutoshi Seto; Hironori Ishibashi; Kenichi Okubo; Shigeru Nemoto; Kazutaka Sumita, Aug. 2022, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 31, 8, 106593, 106593, Scientific journal

  DOI
• Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings., Yosuke Tanaka; Hidetaka Kambayashi; Akiko Yamamoto; Iichiroh Onishi; Keisuke Sugita; Miwa Matsumura; Sachiko Ishibashi; Masumi Ikeda; Kouhei Yamamoto; Masanobu Kitagawa; Morito Kurata, 13 Jul. 2022, International journal of molecular sciences, 23, 14, Scientific journal

  DOI
• Stratification of lung squamous cell carcinoma based on ferroptosis regulators: Potential for new therapeutic strategies involving ferroptosis induction., Ayaka Asakawa; Genji Kawade; Morito Kurata; Sho Fukuda; Iichiroh Onishi; Yuko Kinowaki; Sachiko Ishibashi; Masumi Ikeda; Shiori Watabe; Masashi Kobayashi; Hironori Ishibashi; Kenichi Okubo; Masanobu Kitagawa; Kouhei Yamamoto, 24 Jan. 2022, Lung cancer (Amsterdam, Netherlands), 165, 82, 90, Scientific journal

  DOI
• HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma, Sekine, Y.; Yamamoto, K.; Kurata, M.; Honda, A.; Onishi, I.; Kinowaki, Y.; Kawade, G.; Watabe, S.; Nomura, S.; Fukuda, S.; Ishibashi, S.; Ikeda, M.; Yamamoto, M.; Kitagawa, M., 2022, Pathology, 54, 3, Scientific journal

  DOI
• To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases., Iichiroh Onishi; Kouhei Yamamoto; Yuko Kinowaki; Masanobu Kitagawa; Morito Kurata, 15 Nov. 2021, International journal of molecular sciences, 22, 22, Scientific journal

  DOI
• C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations., Morito Kurata; Iichiro Onishi; Tomoko Takahara; Yukari Yamazaki; Sachiko Ishibashi; Ryo Goitsuka; Daisuke Kitamura; Junko Takita; Yasuhide Hayashi; David A Largaesapda; Masanobu Kitagawa; Takuro Nakamura, 15 Oct. 2021, Cancer science, Scientific journal

  DOI
• Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection., Yoshimori M; Shibayama H; Imadome KI; Kawano F; Ohashi A; Nishio M; Shimizu N; Kurata M; Fujiwara S; Arai A, Apr. 2021, Blood advances, 5, 7, 1805, 1815, Scientific journal

  DOI
• Biliary Peritonitis Caused by Spontaneous Bile Duct Rupture in the Left Triangular Ligament of the Liver after Endoscopic Sphincterotomy for Choledocholithiasis, Fukui, T.; Chochi, T.; Maeda, T.; Lee, C.; Wada, Y.; Ohashi, M.; Tashiro, J.; Arai, M.; Kurata, M.; Yoshida, T.; Konishi, F., 25 Jan. 2021, Case Reports in Gastroenterology, 15, 1, 53, 61, Scientific journal

  DOI
• SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma, Taguchi, T.; Kurata, M.; Onishi, I.; Kinowaki, Y.; Sato, Y.; Shiono, S.; Ishibashi, S.; Ikeda, M.; Yamamoto, M.; Kitagawa, M.; Yamamoto, K., 2021, Laboratory Investigation, 101, 2, 218, 227, Scientific journal

  DOI
• High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma, Yamamoto, A.; Kurata, M.; Yamamoto, K.; Nogawa, D.; Inoue, M.; Ishibashi, S.; Ikeda, M.; Miyasaka, N.; Kitagawa, M., 16 Aug. 2020, Pathology Research and Practice, 216, 11, 153175, 153175, Scientific journal

  DOI
• Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma, Masae Yanai; Morito Kurata; Yutaka Muto; Hiroto Iha; Toshinori Kanao; Anna Tatsuzawa; Sachiko Ishibashi; Masumi Ikeda; Masanobu Kitagawa; Kouhei Yamamoto, 01 Aug. 2020, Pathology, 52, 5, 529, 537, Scientific journal

  DOI
• CRISPR screening identifies M1AP as a new MYC regulator with a promoter-reporter system, Yamamoto, A.; Kurata, M.; Onishi, I.; Sugita, K.; Matsumura, M.; Ishibashi, S.; Ikeda, M.; Yamamoto, K.; Kitagawa, M., 06 May 2020, PeerJ, 2020, 3, e9046, Scientific journal

  DOI
• The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer., Umemori M; Kurata M; Yamamoto A; Yamamoto K; Ishibashi S; Ikeda M; Tashiro K; Kimura T; Sato S; Takahashi H; Kitagawa M, Jan. 2020, Medical molecular morphology, 53, 3, 156, 167, Scientific journal

  DOI
• Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma, Yamamoto, K.; Abe, S.; Honda, A.; Hashimoto, J.; Aizawa, Y.; Ishibashi, S.; Takemura, T.; Hanagata, N.; Yamamoto, M.; Miura, O.; Kurata, M.; Kitagawa, M., 2020, Laboratory Investigation, 100, 3, Scientific journal

  DOI
• 肝転移のみを呈し5年以上生存した原発不明神経内分泌腫瘍の1症例, 村瀬 芳樹; 工藤 篤; 倉田 盛人; 赤星 径一; 小倉 俊郎; 小川 康介; 小野 宏晃; 伴 大輔; 田中 真二; 田邉 稔, Nov. 2019, 25, 53, 57, Scientific journal
• Bone marrow niches in myeloid neoplasms., Kitagawa M; Kurata M; Onishi I; Yamamoto K, Nov. 2019, Pathology international, Scientific journal

  DOI
• Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays, Morito Kurata; Natalie K. Wolf; Walker S. Lahr; Madison T. Weg; Mitchell G. Kluesner; Samantha Lee; Kai Hui; Masano Shiraiwa; Beau R. Webber; Branden S. Moriarity, 17 Sep. 2018, PLOS ONE, 13, 9, e0198714, e0198714, Scientific journal

  DOI
• Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma, Gulinisha Aihemaiti; Morito Kurata; Daichi Nogawa; Akiko Yamamoto; Tatsunori Mineo; Iichiroh Onishi; Yuko Kinowaki; Xiao-Hai Jin; Anna Tatsuzawa; Naoyuki Miyasaka; Masanobu Kitagawa; Kouhei Yamamoto, 15 Jun. 2018, Oncotarget, 9, 46, 28213, 28225, Scientific journal

  DOI
• Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma, Yuko Kinowaki; Morito Kurata; Sachiko Ishibashi; Masumi Ikeda; Anna Tatsuzawa; Masahide Yamamoto; Osamu Miura; Masanobu Kitagawa; Kouhei Yamamoto, 01 May 2018, Laboratory Investigation, 98, 5, 609, 619, Scientific journal

  DOI
• Social stress shortens lifespan in mice., Maria Razzoli; Kewir Nyuyki-Dufe; Allison Gurney; Connor Erickson; Jacob McCallum; Nicholas Spielman; Marta Marzullo; Jessica Patricelli; Morito Kurata; Emily A Pope; Chadi Touma; Rupert Palme; David A Largaespada; David B Allison; Alessandro Bartolomucci, May 2018, Aging Cell, e12778, e12778, Scientific journal

  DOI
• CRISPR/Cas9 library screening for drug target discovery, Morito Kurata; Kouhei Yamamoto; Branden S. Moriarity; Masanobu Kitagawa; David A. Largaespada, 01 Feb. 2018, Journal of Human Genetics, 63, 2, 179, 186

  DOI
• Differential expression of ACINUS variants in bone marrow in myelodysplastic syndromes, Norikazu Miyamoto; Morito Kurata; Toshiya Nagiri; Shinya Abe; Kouhei Yamamoto; Iichiroh Onishi; Susumu Kirimura; Toshihiko Murayama; Michihiro Hidaka; Masanobu Kitagawa, 2017, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 10, 4, 4330, 4338, Scientific journal
• Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML, Morito Kurata; Susan K. Rathe; Natashay J. Bailey; Natalie K. Aumann; Justine M. Jones; G. Willemijn Veldhuijzen; Branden S. Moriarity; David A. Largaespada, Nov. 2016, SCIENTIFIC REPORTS, 6, 36199, 36199, Scientific journal

  DOI
• Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia, Susumu Kirimura; Morito Kurata; Yasunori Nakagawa; Iichiroh Onishi; Shiho Abe-Suzuki; Shinya Abe; Kouhei Yamamoto; Masanobu Kitagawa, 01 Apr. 2016, Pathology, 48, 3, 233, 241, Scientific journal

  DOI
• Extramedullary hematopoiesis: Elucidating the function of the hematopoietic stem cell niche (Review), Kouhei Yamamoto; Yukako Miwa; Shiho Abe-Suzuki; Shinya Abe; Susumu Kirimura; Iichiroh Onishi; Masanobu Kitagawa; Morito Kurata, 01 Jan. 2016, Molecular Medicine Reports, 13, 1, 587, 591

  DOI
• Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors, Shinya Abe; Kouhei Yamamoto; Morito Kurata; Shiho Abe-Suzuki; Rie Horii; Futoshi Akiyama; Masanobu Kitagawa, Oct. 2015, ONCOTARGET, 6, 33, 34892, 34909, Scientific journal

  DOI
• P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases, Mayumi Yoshimori; Honami Takada; Ken-Ichi Imadome; Morito Kurata; Kouhei Yamamoto; Takatoshi Koyama; Norio Shimizu; Shigeyoshi Fujiwara; Osamu Miura; Ayako Arai, Oct. 2015, CANCER MEDICINE, 4, 10, 1494, 1504, Scientific journal

  DOI
• 骨髄組織診断の有用性について, 倉田 盛人; 北川 昌伸, Jan. 2015, 32, 1, 1, 5
• L-Asparaginase monotherapy for EBV-positive T/NK lymphoproliferative diseases: A pilot study, Minako Jinta; Ken-Ichi Imadome; Honami Komatsu; Mayumi Yoshimori; Morito Kurata; Shigeyoshi Fujiwara; Osamu Miura; Ayako Arai, 2015, Journal of Medical and Dental Sciences, 62, 1, 1, 9, Scientific journal

  DOI
• l Expression of multidrug resistance 1 gene in association with CXCL12 in chronic myelogenous leukaemia, Iichiroh Onishi; Yasunori Nakagawa; Toshihiko Murayama; Michihiro Hidaka; Kouhei Yamamoto; Shiho Abe-Suzuki; Shinya Abe; Morito Kurata; Masanobu Kitagawa, Dec. 2014, PATHOLOGY, 46, 7, 623, 629, Scientific journal

  DOI
• CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes, Shiho Abe-Suzuki; Morito Kurata; Shinya Abe; Iichiroh Onishi; Susumu Kirimura; Manami Nashimoto; Toshihiko Murayama; Michihiro Hidaka; Masanobu Kitagawa, 05 Nov. 2014, Laboratory Investigation, 94, 11, 1212, 1223, Scientific journal

  DOI
• CD137 Expression Is Induced by Epstein-Barr Virus Infection through LMP1 in T or NK Cells and Mediates Survival Promoting Signals, Mayumi Yoshimori; Ken-Ichi Imadome; Honami Komatsu; Ludan Wang; Yasunori Saitoh; Shoji Yamaoka; Tetsuya Fukuda; Morito Kurata; Takatoshi Koyama; Norio Shimizu; Shigeyoshi Fujiwara; Osamu Miura; Ayako Arai, Nov. 2014, PLOS ONE, 9, 11, e112564, e112564, Scientific journal

  DOI
• Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides, Daggett, R.N.; Kurata, M.; Abe, S.; Onishi, I.; Miura, K.; Sawada, Y.; Tanizawa, T.; Kitagawa, M., Oct. 2014, British Journal of Dermatology, 171, 4, 722, 731, Scientific journal

  DOI
• Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia, Susan K. Rathe; Branden S. Moriarity; Christopher B. Stoltenberg; Morito Kurata; Natalie K. Aumann; Eric P. Rahrmann; Natashay J. Bailey; Ellen G. Melrose; Dominic A. Beckmann; Chase R. Liska; David A. Largaespada, Aug. 2014, SCIENTIFIC REPORTS, 4, 6048, 6048, Scientific journal

  DOI
• JC Virus Inclusions in Progressive Multifocal Leukoencephalopathy: Scaffolding Promyelocytic Leukemia Nuclear Bodies Grow With Cell Cycle Transition Through an S- to-G2YLike State in Enlarging Oligodendrocyte Nuclei, Shishido-Hara Yukiko; Yazawa Takuya; Nagane Motoo; Higuchi Kayoko; Abe-Suzuki Shiho; Kurata Morito; Kitagawa Masanobu; Kamma Hiroshi; Uchihara Toshiki, May 2014, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 73, 5, 442, 453, Scientific journal

  DOI
• Over-expression of cancerous inhibitor of PP2A (CIP2A) in bone marrow cells from patients with a group of high-risk myelodysplastic syndromes, Li, N.; Abe, S.; Kurata, M.; Abe-Suzuki, S.; Onishi, I.; Kirimura, S.; Murayama, T.; Hidaka, M.; Kawano, F.; Kitagawa, M., 2014, Pathology and Oncology Research, 20, 2, 399, 407, Scientific journal

  DOI
• Infectious mononucleosis accompanied by clonal proliferation of EBV-infected cells and infection of CD8-positive cells, Arai, A.; Yamaguchi, T.; Komatsu, H.; Imadome, K.-I.; Kurata, M.; Nagata, K.; Miura, O., 2014, International Journal of Hematology, 99, 5, 671, 675, Scientific journal

  DOI
• Up-regulated expression of CXCL12 in human spleens with extramedullary haematopoiesis, Miwa, Y.; Hayashi, T.; Suzuki, S.; Abe, S.; Onishi, I.; Kirimura, S.; Kitagawa, M.; Kurata, M., Jun. 2013, Pathology, 45, 4, 408, 416, Scientific journal

  DOI
• [Case of inflammatory lesion in urinary bladder showing high signal intensity on diffusion-weighted MRI: correlation with histopathological finding]., Shingo Moriyama; Soichiro Yoshida; Hideki Takeshita; Morito Kurata; Yohei Okada; Kazutaka Saito; Fumitaka Koga; Hitoshi Masuda; Yasuhisa Fuji; Satoru Kawakami; Kazunori Kihara, May 2013, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 104, 3, 545, 8, Scientific journal
• Erratum to: Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy, Ayako Arai; Ayako Nogami; Ken-Ichi Imadome; Morito Kurata; Naomi Murakami; Shigeyoshi Fujiwara; Osamu Miura, Feb. 2013, International Journal of Hematology, 97, 2, 301, 301, Scientific journal

  DOI
• Expression of multidrug resistance 1 gene in B‐cell lymphomas: association with follicular dendritic cells, Keiko Yagi; Kouhei Yamamoto; Shigeaki Umeda; Shinya Abe; Shiho Suzuki; Iichiroh Onishi; Susumu Kirimura; Masashi Fukayama; Ayako Arai; Masanobu Kitagawa; Morito Kurata, 22 Jan. 2013, Histopathology, 62, 3, 414, 420, Scientific journal

  DOI
• Histological diagnosis of follicular lymphoma by biopsy of small intestinal normal mucosa, Okada, E.; Araki, A.; Suzuki, S.; Watanabe, H.; Ikeda, T.; Watanabe, T.; Kurata, M.; Eishi, Y.; Watanabe, M., 2013, Digestive Endoscopy, 25, 5, Scientific journal

  DOI
• Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy, Arai, A.; Nogami, A.; Imadome, K.-I.; Kurata, M.; Murakami, N.; Fujiwara, S.; Miura, O., Nov. 2012, International Journal of Hematology, 96, 5, 669, 673, Scientific journal

  DOI
• Prognostic significance of HOXB ₄ in de novo acute myeloid leukemia, Umeda, S.; Yamamoto, K.; Murayama, T.; Hidaka, M.; Kurata, M.; Ohshima, T.; Suzuki, S.; Sugawara, E.; Kawano, F.; Kitagawa, M., May 2012, Hematology, 17, 3, 125, 131, Scientific journal

  DOI
• DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells, Naoe Taira; Rei Mimoto; Morito Kurata; Tomoko Yamaguchi; Masanobu Kitagawa; Yoshio Miki; Kiyotsugu Yoshida, Mar. 2012, JOURNAL OF CLINICAL INVESTIGATION, 122, 3, 859, 872, Scientific journal

  DOI
• Giant cell carcinoma causing rapidly progressive respiratory failure as the presenting feature of AIDS, Sugawara, E.; Yamamoto, K.; Umeda, S.; Suzuki, S.; Kurata, M.; Endo, Y.; Uchibori, K.; Akashi, T.; Inase, N.; Kitagawa, M., Feb. 2012, International Journal of STD and AIDS, 23, 7, e7, e8, Scientific journal

  DOI
• Overexpression of MCM2 in myelodysplastic syndromes: Association with bone marrow cell apoptosis and peripheral cytopenia, Shiho Suzuki; Morito Kurata; Shinya Abe; Ryo Miyazawa; Toshihiko Murayama; Michihiro Hidaka; Kouhei Yamamoto; Masanobu Kitagawa, Feb. 2012, EXPERIMENTAL AND MOLECULAR PATHOLOGY, 92, 1, 160, 166, Scientific journal

  DOI
• Minichromosome maintenance 2 bound with retroviral Gp70 is localized to Cytoplasm and enhances DNA-damage-induced apoptosis, Abe, S.; Kurata, M.; Suzuki, S.; Yamamoto, K.; Aisaki, K.-i.; Kanno, J.; Kitagawa, M., 2012, PLoS ONE, 7, 6, e40129, Scientific journal

  DOI
• Primitive neuroectodermal tumor/Ewing's sarcoma of the urinary bladder: a case report and its molecular diagnosis, Yohei Okada; Shigeyoshi Kamata; Takumi Akashi; Morihito Kurata; Takuro Nakamura; Kazunori Kihara, Aug. 2011, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 16, 4, 435, 438, Scientific journal

  DOI
• DNA damage-induced apoptosis and genetic background of the host: Hostspecific signaling enhancers of apoptosis, Kurata, M.; Abe, S.; Suzuki, S.; Li, N.; Ohnishi, I.; Hasegawa, M.; Yamamoto, K.; Kitagawa, M., Jul. 2011, Journal of Medical and Dental Sciences, 58, 2, 85, 88, Scientific journal
• Molecular pathology of myelodysplastic syndromes: Biology of medullary stromal and hematopoietic cells (Review), Masanobu Kitagawa; Morito Kurata; Kouhei Yamamoto; Shinya Abe; Shiho Suzuki; Shigeaki Umeda, Jul. 2011, MOLECULAR MEDICINE REPORTS, 4, 4, 591, 596, Scientific journal

  DOI
• Anti-apoptotic function of Xbp1 as an IL-3 signaling molecule in hematopoietic cells, M. Kurata; Y. Yamazaki; Y. Kanno; S. Ishibashi; T. Takahara; M. Kitagawa; T. Nakamura, Feb. 2011, CELL DEATH & DISEASE, 2, e118, Scientific journal

  DOI
• Localization of the Invadopodia-Related Proteins Actinin-1 and Cortactin to Matrix-Contact-Side Cytoplasm of Cancer Cells in Surgically Resected Lung Adenocarcinomas, Shinichi Hirooka; Takumi Akashi; Noboru Ando; Yoshimi Suzuki; Noriko Ishida; Morito Kurata; Touichirou Takizawa; Kou Kayamori; Kei Sakamoto; Naoyuki Fujiwara; Masao Kojima; Yoshinobu Eishi, 2011, PATHOBIOLOGY, 78, 1, 10, 23, Scientific journal

  DOI
• Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma, Thomas J. Smith; Kouhei Yamamoto; Morito Kurata; Akane Yukimori; Shiho Suzuki; Shigeaki Umeda; Emiko Sugawara; Yousuke Kojima; Motoji Sawabe; Yasunori Nakagawa; Kenshi Suzuki; James T. B. Crawley; Masanobu Kitagawa, Dec. 2010, EXPERIMENTAL AND MOLECULAR PATHOLOGY, 89, 3, 284, 290, Scientific journal

  DOI
• Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia, Nobuo Kuninaka; Morito Kurata; Kouhei Yamamoto; Shiho Suzuki; Shigeaki Umeda; Susumu Kirimura; Ayako Arai; Yasunori Nakagawa; Kenshi Suzuki; Masanobu Kitagawa, Apr. 2010, EXPERIMENTAL AND MOLECULAR PATHOLOGY, 88, 2, 293, 298, Scientific journal

  DOI
• 著明な腫瘍内リンパ球浸潤、特に腫瘍腺管上皮内CD8陽性T細胞の目立った0-Isp型早期胃癌の1症例, 梅田 茂明; 大野 玲; 倉田 盛人; 北川 昌伸; 廣川 勝いく, Jan. 2010, 27, 1, 48, 52
• Depletion or Preservation of Cardiac Sympathetic Nerve - An Autopsy-Verified Contrast in Two Cases of Alzheimer's Disease with or without Lewy Bodies, Shuta Toru; Toshiki Uchihara; Makoto Takahashi; Kazuaki Ichihara; Takashi Endo; Morito Kurata; Masanobu Kitagawa; Katsuiku Hirokawa; Takayoshi Kobayashi, 2010, EUROPEAN NEUROLOGY, 64, 3, 129, 133, Scientific journal

  DOI
• Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia, Toshiki Uchihara; Ken-ichi Ohashi; Masanobu Kitagawa; Morito Kurata; Ayako Nakamura; Katsuiku Hirokawa; Tsutomu Kasuga; Takayoshi Kobayashi, Jan. 2010, ACTA NEUROPATHOLOGICA, 119, 1, 135, 145, Scientific journal

  DOI
• A novel role for acinus and MCM2 as host-specific signaling enhancers of DNA-damage-induced apoptosis in association with viral protein gp70, Maki Hasegawa; Morito Kurata; Kouhei Yamamoto; Kazuko Yoshida; Shirou Aizawa; Masanobu Kitagawa, Aug. 2009, LEUKEMIA RESEARCH, 33, 8, 1100, 1107, Scientific journal

  DOI
• Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry, Yoshinobu Komai; Mutsunori Fujiwara; Yasuhisa Fujii; Hiroyuki Mukai; Junji Yonese; Satoru Kawakami; Shinya Yamamoto; Toshiro Migita; Yuichi Ishikawa; Morito Kurata; Takuro Nakamura; Iwao Fukui, May 2009, CANCER RESEARCH, 69
• Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma, Klio Konstantinou; Kouhei Yamamoto; Fumiaki Ishibashi; Yuiko Mizoguchi; Morito Kurata; Yasunori Nakagawa; Kenshi Suzuki; Motoji Sawabe; Masatsugu Ohta; Shigesaburo Miyakoshi; James T. Crawley; Masanobu Kitagawa, Mar. 2009, BRITISH JOURNAL OF HAEMATOLOGY, 144, 5, 696, 704, Scientific journal

  DOI
• Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry, Yoshinobu Komai; Mutsunori Fujiwara; Yasuhisa Fujii; Hiroyuki Mukai; Junji Yonese; Satoru Kawakami; Shinya Yamamoto; Toshiro Migita; Yuichi Ishikawa; Morito Kurata; Takuro Nakamura; Iwao Fukuil, Feb. 2009, CLINICAL CANCER RESEARCH, 15, 4, 1170, 1176, Scientific journal

  DOI
• Follicular lymphoma with marked infiltration of eosinophils, Junichi Shiraishi; Yasunori Nakagawa; Morito Kurata; Kohei Yamamoto; Yu Abe; Yukitoshi Toyoda; Kenshi Suzuki; Masanobu Kitagawa; Tamiko Takemura, Nov. 2008, PATHOLOGY INTERNATIONAL, 58, 11, 701, 705, Scientific journal

  DOI
• Induction of integrin beta 1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma, Morito Kurata; Yasunori Nakagawa; Kouhei Yamamoto; Kenshi Suzuki; Masanobu Kitagawa, Sep. 2008, AMERICAN JOURNAL OF HEMATOLOGY, 83, 9, 755, 757, Scientific journal

  DOI
• Intravitreal methotrexate was effective in a case of diffuse large B-cell lymphoma with exudative retinal detachment, Yamamoto, S.; Sugita, S.; Iwanaga, Y.; Ishida, T.; Sugamoto, Y.; Mochizuki, M.; Kurata, M.; Kitagawa, M., 2008, Japanese Journal of Clinical Ophthalmology, 62, 9, Scientific journal
• Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells, Shinya Abe; Maki Hasegawa; Kouhei Yamamoto; Morito Kurata; Yasunori Nakagawa; Kenshi Suzuki; Touichiro Takizawa; Masanobu Kitagawa, Dec. 2007, EXPERIMENTAL AND MOLECULAR PATHOLOGY, 83, 3, 405, 412, Scientific journal

  DOI
• Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia, Tamara Keith; Yuko Araki; Masaki Ohyagi; Maki Hasegawa; Kouhei Yamamoto; Morito Kurata; Yasunori Nakagawa; Kenshi Suzuki; Masanobu Kitagawa, May 2007, BRITISH JOURNAL OF HAEMATOLOGY, 137, 3, 206, 215, Scientific journal

  DOI
• Analysis of the regulation of angiogenesis in the bone marrow of myelodysplastic syndrome transforming to overt leukaemia compared to acute myeloid leukaemia, Morito Kurata, 2007, British Journal of Haematology, Scientific journal
• Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes, Morito Kurata; Maki Hasegawa; Yasunori Nakagawa; Shinya Abe; Kouhei Yamamoto; Kenshi Suzuki; Masanobu Kitagawa, Dec. 2006, EXPERIMENTAL AND MOLECULAR PATHOLOGY, 81, 3, 249, 254, Scientific journal

  DOI
• IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes, Yasunori Nakagawa; Shinya Abe; Morito Kurata; Maki Hasegawa; Kouhei Yamamoto; Miori Inoue; Tamiko Takemura; Kenshi Suzuki; Masanobu Kitagawa, Nov. 2006, AMERICAN JOURNAL OF HEMATOLOGY, 81, 11, 824, 831, Scientific journal

  DOI
• [A case of inflammatory myofibroblastic tumor of the urinary bladder finally diagnosed by anaplastic lymphoma kinase (ALK) immunostaining]., Takeshita H; Kawakami S; Okubo Y; Yamamoto S; Yonese J; Fukui I; Kono A; Kurata M; Inoshita N; Ishikawa Y, May 2006, Hinyokika kiyo. Acta urologica Japonica, 52, 5, 375, 378
• Bone marrow cells of myellodysplastic syndromes exhibit significant expression of apollon, livin and ILP-2 with reduction after transformation to overt leukemia, S Abe; K Yamamoto; M Hasegawa; M Inoue; M Kurata; K Hirokawa; M Kitagawa; Y Nakagawa; K Suzuki, Sep. 2005, LEUKEMIA RESEARCH, 29, 9, 1095, 1096, Scientific journal

  DOI
• Cancer and aging: symposium of the 27th annual meeting of the Japanese society for biomedical gerontology, Tokyo, M Kitagawa; M Utsuyama; M Kurata; K Yamamoto; Y Yuasa; Y Ishikawa; T Arai; K Hirokawa, Jul. 2005, CANCER IMMUNOLOGY IMMUNOTHERAPY, 54, 7, 623, 634, Scientific journal

  DOI
• Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL), Y Nakagawa; M Hasegawa; M Kurata; K Yamamoto; S Abe; M Inoue; T Takemura; K Hirokawa; K Suzuki; M Kitagawa, Mar. 2005, AMERICAN JOURNAL OF HEMATOLOGY, 78, 3, 173, 180, Scientific journal

  DOI
• Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia, K Yamamoto; S Abe; Y Nakagawa; K Suzuki; M Hasegawa; M Inoue; M Kurata; K Hirokawa; M Kitagawa, Nov. 2004, LEUKEMIA RESEARCH, 28, 11, 1203, 1211, Scientific journal

  DOI
• A2-Pancortins (Pancortin-3 and-4) are the dominant Pancortins during neocortical development, T Nagano; F Nakamura; D Konno; M Kurata; H Yagi; M Sato, Jul. 2000, JOURNAL OF NEUROCHEMISTRY, 75, 1, 1, 8, Scientific journal

MISC

• hematogone, 大西威一郎; 倉田盛人, 2024, 病理と臨床, 42
• 第17章 血液・骨髄 06 骨髄移植後変化, 倉田盛人, 2024, 42
• 第17章 血液・骨髄 03 異形成と異型, 倉田盛人, 2024, 42
• 第17章 血液・骨髄 02 芽球の割合, 倉田盛人, 2024, 42
• 第17章 血液・骨髄 04 腫瘍性形質細胞, 大西威一郎; 倉田盛人, 2024, 42
• Elucidation of the pathogenesis of acute lymphocytic leukemia using mouse models., 倉田盛人, 2024, 月刊血液内科, 89, 1
• 【治療方針を変える病理所見 診療ガイドラインと治療戦略】(第1部)臓器別 骨髄, 倉田 盛人; 北川 昌伸, Apr. 2021, 39, 臨増, 198, 204
• Analysis of NRAS signaling pathway using CRISPR library, 平河内悠; 平河内悠; 倉田盛人; 古野秀裕; 大西威一郎; 山本浩平; LARGAESPADA David; 山田哲夫; 北川昌伸, 2020, 日本病理学会会誌, 109, 1
• 【新しい解析技術の展開】CRISPR/Cas9 screeningとその応用, 大西 威一郎; 倉田 盛人, Sep. 2019, 72, 3, 287, 292, Introduction commerce magazine
• 【骨髄と脾臓の病理-最近のトピックス-】 脾臓の髄外造血に係る一考察, 山本 浩平; 倉田 盛人, Feb. 2019, 37, 2, 160, 165, Introduction other
• 行政解剖で発見された下垂体原発MALT‐lymphomaが疑われる一例, 濱松晶彦; 濱松晶彦; 倉田盛人; 早川輝; 菊地洋介; 沢辺元司; 新井冨生, Apr. 2018, 日本病理学会会誌, 107, 1, 439, 439
• 甲状腺内に認めた胸腺腫の一例, 木曽 有里; 鈴木 明美; 浜島 裕理; 木下 真由美; 白幡 浩人; 今泉 雅之; 江坂 四季音; 児島 宏哉; 野中 敬介; 相田 順子; 倉田 盛人; 松田 陽子; 新井 冨生, Oct. 2017, 日本臨床細胞学会雑誌, 56, Suppl.2, 795, 795
• 感染がん・炎症がんの分子基盤 EBVはT、NK細胞に感染後AID発現とそれによる遺伝子変異蓄積をもたらし腫瘍発症に寄与する(Molecular mechanisms for infection- and inflammation-associated carcinogenesis EBV induces AID expression in T or NK cells leading to mutagenesis and development of lymphoma), 新井 文子; 倉田 盛人; 藤原 成悦; 三浦 修, Oct. 2013, 日本癌学会総会記事, 72回, 34, 34
• Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy, ARAI Ayako; NOGAMI Ayako; IMADOME Ken-Ichi; KURATA Morito; MURAKAMI Naomi; FUJIWARA Shigeyoshi; MIURA Osamu, 01 Nov. 2012, 96, 5, 669, 673
• DYRK2の発現欠失によるc-Jun/c-Mycの制御異常は細胞の腫瘍化を引き起こす(Dysregulation of c-Jun/c-Myc expression by depletion of DYRK2 triggers tumorigenesis), 平 直江; 三本 麗; 倉田 盛人; 北川 昌伸; 三木 義男; 吉田 清嗣, Aug. 2012, 日本癌学会総会記事, 71回, 71, 71
• MDSの動物モデル, 倉田 盛人; 中村 卓郎, Aug. 2012, 30, 8, 875, 878
• Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma, UCHIDA Emi; HONMA Riko; IGARASHI Aiko; KURATA Morito; IMADOME Ken-Ichi; OMOTO Eijiro; MIURA Osamu; ARAI Ayako, 30 Jan. 2012, 53, 1, 87, 91
• A CASE OF PERITONEAL MESOTHELIOMA TREATED WITH CDDP AND PEMETREXED, UEDA Yoshihiro; ENOMOTO Naoki; MOTOYAMA Kazuo; OONO Ryo; HIROKAWA Katuiku; KURATA Morito, 25 Sep. 2011, 72, 9, 2425, 2430
• DYRK2によるc-Jun/c-Mycのリン酸化は細胞周期G1/S期の進行を制御する(DYRK2-mediated phosphorylation of c-Jun and c-Myc is required for proper control of the G 1/S transition), 平 直江; 三本 麗; 倉田 盛人; 北川 昌伸; 三木 義男; 吉田 清嗣, Sep. 2011, 日本癌学会総会記事, 70回, 99, 99
• DNA損傷アポトーシス増強による癌治療動物モデル, 阿部晋也; 倉田盛人; 山本浩平; 鈴木志保; 梅田茂明; 菅原江美子; 北川昌伸, 2011, 100, 1
• DYRK2は転写因子c-Jun/c-Mycへのリン酸化を介して細胞周期G1/S期の進行を制御する(DYRK2 regulates the G1/S transition by phosphorylation of c-Jun and c-Myc), 平 直江; 三本 麗; 倉田 盛人; 北川 昌伸; 三木 義男; 吉田 清嗣, Aug. 2010, 日本癌学会総会記事, 69回, 373, 374
• P-GLYCOPROTEIN EXPRESSION IS ENHANCED IN EPSTEIN-BARR VIRUS (EBV)-INFECTED T OR NK CELLS AND MAY CAUSE DRUG RESISTANCE OF CHRONIC ACTIVE EBV INFECTION, A. Arai; M. Takahashi; K. Imadome; M. Kurata; T. Koyama; S. Fujiwara; O. Miura, Jun. 2010, HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95, 608, 608, Summary international conference
• 【病理形態学キーワード】血液・骨髄 CD34陽性芽球, 倉田 盛人; 北川 昌伸, Apr. 2010, 28, 臨増, 330, 331
• 悪性リンパ腫組織におけるToll様受容体の発現検討, 山本 浩平; スミス・トーマス; 大西 威一郎; 行森 茜; 小嶋 洋輔; 倉田 盛人; 沢辺 元司; 中川 靖章; 北川 昌伸, Mar. 2010, 日本病理学会会誌, 99, 1, 276, 276
• 横紋筋肉腫様成分を主体とし成熟奇形腫の併存を認めた成人精巣腫瘍の一例, 菅原江美子; 山本浩平; 倉田盛人; 北川昌伸, 2010, 99, 1
• DNA損傷誘発アポトーシス増強による癌治療戦略, 北川昌伸; 倉田盛人; 山本浩平; 鈴木志保; 菅原江美子; 梅田茂明, 2009, 98, 1
• 肺末梢の線毛性粘液結節性乳頭状腫瘍 新entityの提唱と組織学的検討, 平松 美也子; 松本 裕文; 松田 正典; 二宮 浩範; 倉田 盛人; 稲村 健太郎; 佐藤 之俊; 石川 雄一; 土屋 永寿, Sep. 2005, 64回, 398, 398

Books etc

• 見逃してはならない血液疾患 : 病理からみた44症例 : blood diseases, Contributor, Apr. 2014, x, 278p, ISBN: 9784260016742

Presentations

• 骨髄の病理:基礎から病理診断まで 骨髄の病理診断, 大西 威一郎; 倉田 盛人; 山本 浩平; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• 脱細胞化骨への侵入に必要な間葉系幹細胞の因子の同定, 小柳 杏莉; 大西 威一郎; 倉田 盛人; 藪中 傑; 木村 剛; 岸田 晶夫; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• 肝細胞癌における4-hydroxylnonenal蓄積の臨床病理学的検討及び4-hydroxylnonenal代謝カスケードの検索, 川出 玄二; 山本 浩平; 龍澤 杏奈; 有賀 縁; 大西 威一郎; 倉田 盛人; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• 前立腺癌Gleason pattern4におけるcircularPVT1発現依存的なMYC発現, 梅森 宮加; 倉田 盛人; 田代 康次郎; 佐藤 峻; 鷹橋 浩幸; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• RNA sequencingにより、transposon mutagenesisに誘発されるマウス腫瘍の"molecular pathology"が明らかになる(RNA sequencing reveals the "molecular pathology" of mouse tumors induced by transposon mutagenesis), Largaespada David A; Kurata Morito; Pope Emily A; Beckmann Pauli J; Larson Jon D; Shu Jingmin; Temiz Nuri A; Sarver Aaron L; Seshagiri Somasekar, 日本病理学会会誌, 01 Mar. 2021, English, International conference
• EB virus in situ hybridizationとT細胞マーカー二重染色法の検討, 綾部 真弥; 倉田 盛人; 関根 正喜; 杉田 佳祐; 大西 威一郎; 山本 浩平; 新井 文子; 明石 巧; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• CRISPR KO libraryを用いた細胞間相互作用により誘導される薬剤耐性の解明, 杉田 佳祐; 倉田 盛人; 中山 蘭; 大西 威一郎; 山本 浩平; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• CRISPR activation libraryを用いたNRASシグナルの解析, 平河内 悠; 倉田 盛人; 古野 秀裕; 亘 優季; 大西 威一郎; 山本 浩平; Largaespada David; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• CRISPR activation libraryを用いたMYCの転写活性化因子の探求, 田中 陽典; 倉田 盛人; 上林 秀孝; 亘 優季; 山本 阿紀子; 大西 威一郎; 山本 浩平; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2021, Japanese, Domestic conference
• CRISPR libraryを用いたNRAS発現調整可能THP-1細胞株によるシグナル解析, 倉田 盛人; 大西 威一郎; 山本 浩平; 北川 昌伸, 日本癌学会総会記事, 01 Oct. 2020, English, Domestic conference
• びまん性大細胞性リンパ腫においてSECISBP2はセレノプロテインを調整する新規の予後予測因子になりうる, 田口 登和子; 山本 浩平; 木脇 祐子; 大西 威一郎; 倉田 盛人; 山本 正英; 北川 昌伸, 日本癌学会総会記事, 01 Oct. 2020, English, Domestic conference
• 肝細胞癌におけるGPX4発現の臨床病理学的検討, 川出 玄二; 山本 浩平; 立澤 杏奈; 矢内 雅恵; 倉田 盛人; 北川 昌伸, 日本癌学会総会記事, 01 Oct. 2020, English, Domestic conference
• 脱細胞化骨を用いた、ヒト骨髄微小環境再構築の試み, 大西 威一郎; 倉田 盛人; 山本 浩平; 木村 剛; 岸田 晶夫; 北川 昌伸, 日本癌学会総会記事, 01 Oct. 2020, English, Domestic conference
• 骨髄の病理とゲノム異常 骨髄微小環境の変化からみた骨髄系腫瘍の病態把握, 山本 浩平; 倉田 盛人; 大西 威一郎; 桐村 進; 木脇 祐子; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• 脱細胞化骨組織を用いたヒト骨髄微小環境の構築, 大西 威一郎; 倉田 盛人; 山本 浩平; 木村 剛; 岸田 晶夫; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• 肝細胞癌におけるGPX4の臨床病理学的検討, 川出 玄二; 山本 浩平; 立澤 杏奈; 大西 威一郎; 倉田 盛人; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• 悪性リンパ腫におけるSBP2とセレノプロテイン発現についての臨床病理学的検討, 田口 登和子; 山本 浩平; 倉田 盛人; 大西 威一郎; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• トランスポゾン変異を用いた乳癌におけるPI3キナーゼ変異協調遺伝子の同定, 倉田 盛人; 山本 浩平; David Largaespada; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• CRISPR libraryを用いたNRASシグナルの解析, 平河内 悠; 倉田 盛人; 古野 秀裕; 大西 威一郎; 山本 浩平; David Largaespada; 山田 哲夫; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• CRISPR libraryを用いたMYCの転写活性の制御に関わる分子のスクリーニング, 中山 蘭; 倉田 盛人; 山本 阿紀子; 山本 浩平; 大西 威一郎; 小松 博義; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• CRISPR KO libraryを用いた細胞相互作用における薬剤耐性機序の解明, 杉田 佳祐; 倉田 盛人; 中山 蘭; 大西 威一郎; 山本 浩平; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• CAEBV診断に向けたEB virus in situ hybridizationとT細胞マーカー2重染色法の検証, 綾部 真弥; 倉田 盛人; 関根 正喜; 杉田 佳祐; 大西 威一郎; 山本 浩平; 新井 文子; 明石 巧; 北川 昌伸, 日本病理学会会誌, 01 Mar. 2020, Japanese, Domestic conference
• 卵巣癌におけるMCM2タンパクの細胞内局在に着目した臨床病理学的検討(Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma), 野川 大地; グリニサ・アヒマティ; 山本 阿紀子; 大西 威一郎; 倉田 盛人; 宮坂 尚幸; 山本 浩平; 北川 昌伸, 日本癌学会総会記事, 01 Sep. 2019, English, Domestic conference
• ラノラジンは難治性悪性リンパ腫に対する有望な抗腫瘍薬としての可能性を有する(Ranolazine is a potential anti-tumor reagent against refractory cases in malignant lymphoma), 山本 浩平; 阿部 晋也; 倉田 盛人; 本田 彩華; 山本 正英; 北川 昌伸, 日本癌学会総会記事, 01 Sep. 2019, English, Domestic conference
• PI3K変異型乳癌における新規協調癌遺伝子とシグナル探索(Discovery of cancer genes and pathways operative in PI3K activated mammary cancer), 倉田 盛人; 山本 浩平; 北川 昌伸, 日本癌学会総会記事, 01 Sep. 2019, English, Domestic conference
• 卵巣癌におけるPVT1、MYCの発現と予後に関する検討, 山本 阿紀子; 倉田 盛人; Aihemaiti Gulinisha; 野川 大地; 矢内 雅恵; 山本 浩平; 北川 昌伸, 日本婦人科腫瘍学会雑誌, 01 Jun. 2019, Japanese, Domestic conference
• CRISPR libraryを用いた細胞相互作用における薬剤耐性機序の解明, 杉田 佳祐; 倉田 盛人; 中山 蘭; 大西 威一郎; 山本 浩平; 北川 昌伸, 日本病理学会会誌, 01 Apr. 2019, Japanese, Domestic conference
• NRAS発現量依存的な細胞老化シグナルの解析, 倉田 盛人; 山本 浩平; Rathe Susan; Largaespada David; 北川 昌伸, 日本病理学会会誌, 01 Apr. 2019, Japanese, Domestic conference
• オートファゴソーム形成に着目した骨髄異形成症候群の予後解析, 大西 威一郎; 倉田 盛人; 山本 浩平; 北川 昌伸, 日本病理学会会誌, 01 Apr. 2019, Japanese, Domestic conference
• ラノラジンは難治性悪性リンパ腫に対する有望な抗腫瘍薬としての可能性を有する(Ranolazine is a potential anti-tumor reagent against refractory cases in malignant lymphoma), 山本 浩平; 阿部 晋也; 本田 彩華; 山本 正英; 三浦 修; 倉田 盛人; 北川 昌伸, 日本病理学会会誌, 01 Apr. 2019, English, Domestic conference
• 前立腺癌におけるPVT1の病理学的検討, 梅森 宮加; 倉田 盛人; 佐藤 峻; 鷹橋 浩幸; 北川 昌伸, 日本病理学会会誌, 01 Apr. 2019, Japanese, Domestic conference
• 卵巣癌におけるMCM2タンパクの細胞内局在に着目した臨床病理学的検討(Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma), 野川 大地; グリニサ・アヒマティ; 山本 阿紀子; 立澤 杏奈; 峰尾 竜徳; 大西 威一郎; 倉田 盛人; 宮坂 尚幸; 山本 浩平; 北川 昌伸, 日本病理学会会誌, 01 Apr. 2019, English, Domestic conference
• NRAS発現調整可能システムとシグナルの解析(Controllable NRAS expression system and analysis of different signals), 倉田 盛人; 山本 浩平; 北川 昌伸, 日本癌学会総会記事, 01 Sep. 2018, English, Domestic conference
• ラノラジンは難治性悪性リンパ腫に対する有望な抗腫瘍薬としての可能性を有する(Ranolazine is a potential anti-tumor reagent against refractory cases in malignant lymphoma), 山本 浩平; 阿部 晋也; 倉田 盛人; 本田 彩華; 山本 正英; 北川 昌伸, 日本癌学会総会記事, 01 Sep. 2018, English, Domestic conference
• 卵巣癌におけるMCM2タンパクの細胞内局在に着目した臨床病理学的検討(Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma), 野川 大地; グリニサ・アヒマティ; 山本 阿紀子; 大西 威一郎; 倉田 盛人; 宮坂 尚幸; 山本 浩平; 北川 昌伸, 日本癌学会総会記事, 01 Sep. 2018, English, Domestic conference
• Epstein-Barr Virus Induces Activation-Induced Cytidine Deaminase Expression in T or NK Cells Leading to Mutagenesis and Development of Lymphoma, Ayako Arai; Masato Horino; Ken-Ichi Imadome; Kohsuke Mai; Honami Komatsu; Ludan Wang; Go Matsuda; Kasumi Hamazaki; Morito Kurata; Tetsuya Kurosu; Shigeyoshi Fujiwara; Osamu Miura, BLOOD, Nov. 2013, Nov. 2013, Nov. 2013, English
• 感染がん・炎症がんの分子基盤 EBVはT、NK細胞に感染後AID発現とそれによる遺伝子変異蓄積をもたらし腫瘍発症に寄与する(Molecular mechanisms for infection- and inflammation-associated carcinogenesis EBV induces AID expression in T or NK cells leading to mutagenesis and development of lymphoma), 新井 文子; 倉田 盛人; 藤原 成悦; 三浦 修, 日本癌学会総会記事, Oct. 2013, Oct. 2013, Oct. 2013, English
• 拡散強調MR画像にて高信号を呈した膀胱炎症性病変の1例 組織学的所見との比較による考察, 森山 真吾; 吉田 宗一郎; 竹下 英毅; 倉田 盛人; 岡田 洋平; 斎藤 一隆; 古賀 文隆; 増田 均; 藤井 靖久; 川上 理; 木原 和徳, 日本泌尿器科学会雑誌, May 2013, May 2013, May 2013, Japanese
• Erratum: Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy (International Journal of Hematology (2012) 96 (669-673) DOI: 10.1007/s12185-012-1170-2)), Ayako Arai; Ayako Nogami; Ken Ichi Imadome; Morito Kurata; Naomi Murakami; Shigeyoshi Fujiwara; Osamu Miura, International Journal of Hematology, 01 Feb. 2013, 01 Feb. 2013, 01 Feb. 2013
• DYRK2の発現欠失によるc-Jun/c-Mycの制御異常は細胞の腫瘍化を引き起こす(Dysregulation of c-Jun/c-Myc expression by depletion of DYRK2 triggers tumorigenesis), 平 直江; 三本 麗; 倉田 盛人; 北川 昌伸; 三木 義男; 吉田 清嗣, 日本癌学会総会記事, Aug. 2012, Aug. 2012, Aug. 2012, English
• 血漿中EBV-DNA量を経時的に測定したEBV陽性Hodgkin リンパ腫, 内田慧美; 本間りこ; 五十嵐愛子; 倉田盛人; 今留謙一; 大本英次郎; 三浦修; 新井文子, 臨床血液, Feb. 2012, Feb. 2012, Feb. 2012, Japanese
• DYRK2によるc-Jun/c-Mycのリン酸化は細胞周期G1/S期の進行を制御する(DYRK2-mediated phosphorylation of c-Jun and c-Myc is required for proper control of the G 1/S transition), 平 直江; 三本 麗; 倉田 盛人; 北川 昌伸; 三木 義男; 吉田 清嗣, 日本癌学会総会記事, Sep. 2011, Sep. 2011, Sep. 2011, English
• PARTICIPATION IN CHRONIC MYELOID LEUKEMIA (CML) IN APPEARANCE AND IMATINIB RESISTANCE OF MULTI-DRUG RESISTANCE(MDR), Yasunori Nakagawa; Morito Kurata; Kenshi Suzuki; Masanobu Kitagawa, ANNALS OF ONCOLOGY, Nov. 2010, Nov. 2010, Nov. 2010, English
• DYRK2は転写因子c-Jun/c-Mycへのリン酸化を介して細胞周期G1/S期の進行を制御する(DYRK2 regulates the G1/S transition by phosphorylation of c-Jun and c-Myc), 平 直江; 三本 麗; 倉田 盛人; 北川 昌伸; 三木 義男; 吉田 清嗣, 日本癌学会総会記事, Aug. 2010, Aug. 2010, Aug. 2010, English

Awards

• Pathology Research Award, The Japanese Society of Pathology, Nov. 2023
• 2010

Research Projects

• Development of AI to help pathological diagnosis, and assimilation and construction of "AI medical image" knowledge (JP20lk1010027), Masanobu Kitagawa; Masashi Fukayama; Hiroyuki Abe; Akihiko Yoshizawa; Kohei Yamamoto; Yasuhiro Sakai; Morito Kurata; Eiichi Morii; Hiroshi Nanjo; Tetsuo Ushiku; Takayuki Honda; Chiho Obayashi; Koji Arihiro; Masayuki Noguchi; Hironori Haga; Hiroshi Uozaki; Kento Aida; Kazuhiko Ohe, Japan Agency for Medical Research and Development (AMED), ICT infrastructure establishment and implementation of artificial intelligence for clinical and medical research, The Japanese Society of Pathology, Apr. 2020, Jul. 2021, Competitive research funding, No international co-authorship, JP20lk1010027
• 2018, 2020, Principal investigator, Competitive research funding
• Development of anti-tumor therapy model using MCM2 function, KITAGAWA Masanobu, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Tokyo Medical and Dental University, 01 Apr. 2012, 31 Mar. 2015, The interaction of viral proteins with host-cellular proteins elicits the activation of cellular signal transduction pathways. Previously, we have clarified that an infection with Friend leukemia virus (FLV) markedly enhanced the IR-induced apoptosis of hematopoietic cells in C3H mice in association with P53, ATM, and DNA-PK. The host specificity of this phenomenon was caused by the up-regulated expression of minichromosome maintenance (MCM) 2 in C3H mice. Furthermore, combined FLV and doxorubicin treatment extended the survival of SCID mice bearing MCM2-highly expressing 8047 leukemia cells., 24590476

  対象リソースIRI
• A new mouse model of acute B lymphocytic leukemia (B-ALL), KURATA Morito, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B), Grant-in-Aid for Young Scientists (B), Tokyo Medical and Dental University, 2011, 2012, Blnk (Bash/SLP-65) encodes an adaptor protein of the B-cell receptor signaling and functions as a tumor suppressor. Loss of function mutations of BLNK have been observed in human preB-ALL, however, only a subset of Blnk ko mice develop preB-ALL, suggesting that cooperative events with Blnk deficiency are required for complete leukemogenesis. Retroviral tagging was performed to identify the cooperative genes, and the Cebpb locus was the most frequent common integration site. Cebpb encodes two protein isoforms of LAP and LIP. Transgenic mice bearing LAP or LIP were generated, mated with Blnk ko mice, and transgenic expression of LAP significantly accelerated the ALL onset of Blnkko/ko mice. Moreover, significant decrease of mature B-cells and increase of IL-7Rα-positive fractions in the bone marrow of non-neoplastic Blnkko/ko/LAP tg mice was evident. Knockdown of C/EBP〓 in a human preB-ALL cell line lacking BLNK expression suppressed cellular growth. These results indicate that C/EBP〓 LAP promotes leukemogenesis in the absence of BLNK including human B-ALL., 23790434

  対象リソースIRI
• Development of novel therapeutic strategy against tumor progression using animal model, KITAGAWA Masanobu, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Tokyo Medical and Dental University, 2009, 2011, The interaction of viral proteins with host-cellular proteins elicits the activation of cellular signal transduction pathways. Previously, we have clarified that an infection with Friend leukemia virus(FLV) markedly enhanced the IR-induced apoptosis of hematopoietic cells in C3H mice in association with P53, ATM, and DNA-PK. The phenomenon was characterized in vivo by severe anemia when the mice were infected with FLV and then treated with a low dose of total body irradiation(TBI). Viral infection and replication occurred almost cell type-specifically in the hematopoietic cells and thus, the apoptotic enhancement was observed only in the hematopoietic cells. However, p53 knockout mice, Atm knockout mice, and DNA-PK-deficient SCID mice with a C3H background did not exhibit this phenotype. A comparison of apoptotic signals after FLV, TBI, or FLV+TBI treatment of these mice revealed that ATM appeared to be necessary for the general signal transduction of TBI-induced apoptosis, while DNA-PK had a specific role in enhancing p53-dependent apoptosis under FLV infection. The host specificity of this phenomenon was caused by the up-regulated expression of Acinus and minichromosome maintenance(MCM) 2 in C3H mice. We also showed that C3H mouse-derived hematopoietic cells originally expressed higher levels of MCM2 than BALB/c cells and exhibited more frequent apoptosis after DNA-damage by doxorubicin when the cells expressed the Friend leukemia virus envelope protein gp70. Transduction and immunoprecipitation assays using various deletion mutants of, 21590432

  対象リソースIRI
• The function of Xbp-1 under the IL-3 signaling in hematopoiesis and leukemogenesis, KURATA Morito; NAKAMURA Takuro; KITAGAWA Masanobu, Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (Start-up), Grant-in-Aid for Young Scientists (Start-up), Tokyo Medical and Dental University, 2007, 2008, 19890061

  対象リソースIRI
• Competitive research funding

  対象リソースIRI

Educational Activities

Teaching Experience

• Hematooncology, Tokyo Medical and Dental University, 2017, 9999
• Oncology, Tokyo Medical and Dental University, 2009, 9999
• Pathology, Tokyo Medical and Dental University, 2007, 9999

Social Contribution

Social Contribution

• Guest editor, International Journal of Molecular Sciences, Aug. 2021, Aug. 2022

Media Coverage

• TMDU achieves identification of molecules involved of drug resistance in cancer microenvironment by new screening method, 17 Aug. 2023, Paper